Josiah Hornblower
Executive Officer, Director at Kayak Therapeutics.
Raised on Kayak Therapeutics filings
$11.9M
of $25M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 3
- Last filing
- May 27, 2026
Company
TRIM7 inhibitors for RAS-driven solid tumors
- Investors
- 55
- Founded
- 2025
- Still open
- $13.1M
Kayak Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| May 27, 2026 | Security to be acquired | $11.9M/ $25M | Form D |
- Security to be acquiredFiled May 27, 2026Form D$11.9M/ $25M
